Journal of Medicinal Chemistry · 2009 · 170 citations · 30 references
Life SciencesMedicinal ChemistryPharmacologyDrug DiscoveryEndocytosisMolecular PharmacologyClathrin-mediated EndocytosisEnzyme InhibitionLigand BindingPotency OptimizationReceptor-mediated EndocytosisStructure-activity Relationship AnalysisDynamin-dependent InternalizationDynamin-mediated EndocytosisTransferrin Uptake
Screening identified two bisindolylmaleimides as 100 microM inhibitors of the GTPase activity of dynamin I. Focused library approaches allowed development of indole-based dynamin inhibitors called dynoles. 100-Fold in vitro enhancement of potency was noted with the best inhibitor, 2-cyano-3-(1-(2-(dimethylamino)ethyl)-1H-indol-3-yl)-N-octylacrylamide (dynole 34-2), a 1.3 +/- 0.3 microM dynamin I inhibitor. Dynole 34-2 potently inhibited receptor mediated endocytosis (RME) internalization of Texas red-transferrin. The rank order of potency for a variety of dynole analogues on RME in U2OS cells matched their rank order for dynamin inhibition, suggesting that the mechanism of inhibition is via dynamin. Dynoles are the most active dynamin I inhibitors reported for in vitro or RME evaluations. Dynole 34-2 is 15-fold more active than dynasore against dynamin I and 6-fold more active against dynamin mediated RME (IC(50) approximately 15 microM; RME IC(50) approximately 80 microM). The dynoles represent a new series of tools to better probe endocytosis and dynamin-mediated trafficking events in a variety of cells.
30
Dynasore, a Cell-Permeable Inhibitor of Dynamin
Eric Macia, Marcelo Ehrlich, Ramiro Massol et al. · Developmental Cell · 2006 · 2K citations · Full text